Cargando…
Provider‐ and patient‐level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma
BACKGROUND: Improving oral anticancer agent (OAA) initiation and adherence is the important quality‐of‐care issues, particularly since one fourth of anticancer agents being developed will be administered orally. Our objective was to identify provider‐ and patient‐level characteristics associated wit...
Autores principales: | Spees, Lisa P., Wheeler, Stephanie B., Jackson, Bradford E., Baggett, Christopher D., Wilson, Lauren E., Greiner, Melissa A., Kaye, Deborah R., Zhang, Tian, George, Daniel, Scales, Charles D., Pritchard, Jessica E., Leapman, Michael, Gross, Cary P., Dinan, Michaela A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495289/ https://www.ncbi.nlm.nih.gov/pubmed/34480518 http://dx.doi.org/10.1002/cam4.4201 |
Ejemplares similares
-
Real-World Utilization of Oral Anticancer Agents and Related Costs in Older Adults with Metastatic Renal Cell Carcinoma in the United States
por: Wilson, Lauren E., et al.
Publicado: (2021) -
Disparities in immune and targeted therapy utilization for older US patients with metastatic renal cell carcinoma
por: Chow, Ryan D, et al.
Publicado: (2023) -
Adoption of New Risk Stratification Technologies Within US Hospital Referral Regions and Association With Prostate Cancer Management
por: Leapman, Michael S., et al.
Publicado: (2021) -
Risk factors for dementia onset in older adults with metastatic renal cell carcinoma
por: Miller, Samuel, et al.
Publicado: (2021) -
Relative Burden of Cancer and Noncancer Mortality Among Long-Term Survivors of Breast, Prostate, and Colorectal Cancer in the US
por: KC, Madhav, et al.
Publicado: (2023)